ActiTrexx GmbH

About:

ActiTrexx GmbH is a stem cell transplantation center that offers curative and cellular therapies.

Top Investors: HTGF | High-Tech Gruenderfonds, LBBW VC, Investitions- und Strukturbank Rheinland-Pfalz, MediVentures

Description:

ActiTrexx GmbH is a biotech start-up. They offer cellular therapy to prevent inflammatory reactions in conditions like GVHD, solid organ transplantation, and autoimmune diseases. Their ATREGA is a treatment option for transplanted patients, providing a substantial survival rate.

Total Funding Amount:

3.5M EUR

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Mainz, Rheinland-Pfalz, Germany

Founded Date:

2019-01-01

Contact Email:

info(AT)actitrexx.de

Founders:

Andrea Tüttenberg

Number of Employees:

1-10

Last Funding Date:

2021-03-02

IPO Status:

Private

Industries: